Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

As Brazil's COVID-19 testing lags, available labs go unused

Published 04/15/2020, 04:23 PM
Updated 04/15/2020, 06:20 PM
© Reuters. FILE PHOTO: The coronavirus disease (COVID-19) outbreak in Brazil

By Ana Mano

SAO PAULO (Reuters) - Despite Brazil's backlog of more than 90,000 specimens awaiting coronavirus testing and a rising death toll, laboratories are idle due to a lack of materials, the agriculture ministry said.

Brazil's agriculture ministry told Reuters in a written response to questions earlier this week that seven labs it had made available for coronavirus testing and which were cleared by the health regulator two weeks ago are still not being used for tests.

The ministry said the facilities could process an initial 12,000 tests per week but are not receiving the necessary reagents for testing.

Separately, Brazil's agronomics research agency Embrapa, which falls under the agriculture ministry, said its labs could process almost 43,000 tests per day.

In an emailed response to questions, Brazil's Health Ministry did not directly address why the available labs were not being used.

It said it was striving to increase testing capacity despite a "shortage of inputs and the high global demand for testing kits."

The public health system has performed 89,000 tests for COVID-19, the health ministry statement said. On Monday the ministry said there were a total of 93,000 pending tests.

Brazil was slow to implement widespread testing despite the recommendation of the World Health Organization to "test, test, test," but has in recent weeks sought to scale up.

The lack of testing means Brazil, the worst hit country in Latin America, likely has 12 times more cases of the new coronavirus than are being officially reported, according to one study.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

The government on Wednesday reported 28,320 confirmed COVID-19 cases in Brazil and 1,736 deaths.

The agriculture ministry said: "The labs are waiting for the purchase of reagents and inputs to conduct the tests."

The health ministry said 451,432 tests have been distributed to states but did not specify if any of these would be used in the agriculture ministry's labs.

A government source said one of the major problems was a lack of coordination.

"I don't see planned action, coordinated between the health ministry and the agriculture ministry," the source, who is directly familiar with the matter, told Reuters on condition of anonymity because they are not permitted to speak publicly.

The source said a lack of reagents could be overcome by developing new protocols using alternative bio-chemicals. In a statement on Wednesday, the agriculture ministry confirmed new protocols may be adopted to increase testing at its labs network.

The health ministry did not address this question in its response.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.